Blood · 2005 · 112 citations · 13 references
MedicineOncologyPathologyHematologic OncologyMolecular OncologyNeoplasiaCirculating Tumor CellsHematologic MalignanciesHematopoietic NeoplasmsMalignant NeoplasmsMultiple MyelomaPlasma Cell NeoplasmsChromosome 13Q LossCirculating Tumor Cell CharacterizationMyeloid NeoplasmsMyeloma Pathogenesis
In multiple myeloma (MM), circulating endothelial cells (CECs) represent a vascular marker of angiogenesis and may reflect tumor mass. In this report, we showed that, in 5 MM patients with 13q14 deletion, CECs carried the same chromosome aberration as the neoplastic plasma cells (11%-32% of CECs with 13q14 deletion). Most of the CECs displayed immunophenotypic features of endothelial progenitor cells as they expressed CD133, a marker gradually lost during endothelial differentiation and absent on mature endothelial cells. To the contrary, in 3 patients with monoclonal gammopathy of undetermined significance and 13q14 deletion, CECs were cytogenetically normal and had a mature immunophenotype. In MM CECs, immunoglobulin genes were clonally rearranged. These findings suggest a possible origin of CECs from a common hemangioblast precursor that can give rise to both plasma cells and endothelial cells and point to a direct contribution of MM-derived CECs to tumor vasculogenesis and possibly to the spreading and progression of the disease.
13
Contribution of bone marrow–derived endothelial cells to human tumor vasculature
Brock A. Peters, Luis A. Díaz, Kornélia Polyák et al. · Nature Medicine · 2005 · 480 citations
Medicine, Cancer Biology, Oncology +16
Resting and activated endothelial cells are increased in the peripheral blood of cancer patients
Patrizia Mancuso, Alessandra Burlini, Giancarlo Pruneri et al. · Blood · 2001 · 419 citations · Full text
Medicine, Cell Biology, Oncology +12